These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 1199668)

  • 41. Wilson's disease: a common liver disorder?
    Thompson WG; Hyslop PS; Barr R; Sass-Kortsak A
    Can Med Assoc J; 1977 Jul; 117(1):45-8. PubMed ID: 861910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Penicillamine treatment of Wilson's disease].
    Falkmer S; Samuelson G; Sjölin S
    Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract]   [Full Text] [Related]  

  • 43. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease.
    LaRusso NF; Summerskill WH; McCall JT
    Gastroenterology; 1976 May; 70(5 PT.1):653-5. PubMed ID: 1261757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrahepatocellular localization of copper in Wilson's disease.
    Yano M; Sakamoto N; Takikawa T; Hayashi H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):131-7. PubMed ID: 8247102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregnancy in Wilson's disease.
    Walshe JM
    Q J Med; 1977 Jan; 46(181):73-83. PubMed ID: 866569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tissue copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron activation analysis.
    Yeh SJ; Leu ML; Strickland GT
    J Lab Clin Med; 1971 Mar; 77(3):438-44. PubMed ID: 5553728
    [No Abstract]   [Full Text] [Related]  

  • 48. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Wilson's disease: physiopathology, therapeutic approach and case report].
    Gallo V; Riva P; Sidoli L; Bisbocci D
    Minerva Gastroenterol Dietol; 1994 Dec; 40(4):197-201. PubMed ID: 7849148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
    Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P
    Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary copper excretion and hepatic copper concentrations in liver disease.
    Frommer DJ
    Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease.
    Foruny JR; Boixeda D; López-Sanroman A; Vázquez-Sequeiros E; Villafruela M; Vázquez-Romero M; Rodríguez-Gandía M; de Argila CM; Camarero C; Milicua JM
    Scand J Gastroenterol; 2008; 43(5):597-603. PubMed ID: 18415754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients.
    Walshe JM
    Q J Med; 1989 Mar; 70(263):253-63. PubMed ID: 2602537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
    Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Wilson's disease and secondary copper hemochromatoses in hematological practice].
    Vorob'ev AI; Lukina EA; Sysoeva EP; Levina AA; Solov'eva TI
    Ter Arkh; 2004; 76(7):55-9. PubMed ID: 15379129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular manifestations of Wilson's disease in Iran.
    Kashani AA
    Trans Ophthalmol Soc U K (1962); 1977 Apr; 97(1):18-9. PubMed ID: 271391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
    Schmid-Rüter E; Feist D; Wesch H; Rossner JA; Schärer K
    Dtsch Med Wochenschr; 1973 Sep; 98(37):1698-703. PubMed ID: 4125854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.